(Q42276755)

19 October 2017

Pulmonary invasive mucormycosis in a patient with secondary iron overload following deferoxamine therapy (English)

1 reference

19 October 2017

1 reference

1 reference

Hector M Reyes

1

1 reference

19 October 2017

Eric J Tingle

2

1 reference

19 October 2017

Andrew Z Fenves

3

1 reference

19 October 2017

Jennifer Spiegel

4

1 reference

19 October 2017

Elizabeth C Burton

5

1 reference

19 October 2017

1 October 2008

1 reference

Baylor University Medical Center Proceedings

19 October 2017

1 reference

19 October 2017

21

1 reference

19 October 2017

4

1 reference

19 October 2017

378-381

1 reference

Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566908

Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566908

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566908

Mucormycosis: association with deferoxamine therapy

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566908

Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566908

Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566908

Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis).

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566908

Effects of iron and desferrioxamine on Rhizopus infection.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2566908

Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients

29 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18982078

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/18982078

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/18982078

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

19 October 2017

PubMed publication ID

18982078

1 reference